9-dibenzofuran-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-dibenzothiophen-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3,5-diphenylphenyl)-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzofuran-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzothiophen-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(3-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(4-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene

C428H256N32O2S2 — CID 158556429

About 9-dibenzofuran-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-dibenzothiophen-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3,5-diphenylphenyl)-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzofuran-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzothiophen-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(3-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(4-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene

9-dibenzofuran-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-dibenzothiophen-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3,5-diphenylphenyl)-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzofuran-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzothiophen-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(3-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(4-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene (PubChem CID 158556429) has the molecular formula C428H256N32O2S2 and a molecular weight of 5943.11 g/mol. Its IUPAC name is 9-dibenzofuran-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-dibenzothiophen-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3,5-diphenylphenyl)-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzofuran-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzothiophen-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(3-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(4-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene.

Molecular Properties

• Compound Name: 9-dibenzofuran-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-dibenzothiophen-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3,5-diphenylphenyl)-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzofuran-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzothiophen-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(3-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(4-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene
• PubChem CID: 158556429
• Molecular Formula: C428H256N32O2S2
• Molecular Weight: 5943.11 g/mol
• Exact Mass: 5938.04
• IUPAC Name: 9-dibenzofuran-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-dibenzothiophen-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3,5-diphenylphenyl)-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzofuran-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzothiophen-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(3-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(4-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene
• SMILES: c1cc(-c2cnc3c4ccccc4c4ccccc4c3n2)cc(-n2c3ccccc3c3c4c5ccccc5n(-c5cccc6c5oc5ccccc56)c4ccc32)c1.c1cc(-c2cnc3c4ccccc4c4ccccc4c3n2)cc(-n2c3ccccc3c3c4c5ccccc5n(-c5cccc6c5sc5ccccc56)c4ccc32)c1.c1ccc(-c2cc(-c3ccccc3)cc(-n3c4ccccc4c4c5c6ccccc6n(-c6cccc(-c7cnc8c9ccccc9c9ccccc9c8n7)c6)c5ccc43)c2)cc1.c1ccc(-c2ccc(-n3c4ccccc4c4c5c6ccccc6n(-c6cccc(-c7cnc8c9ccccc9c9ccccc9c8n7)c6)c5ccc43)cc2)cc1.c1ccc(-c2cccc(-n3c4ccccc4c4c5c6ccccc6n(-c6cccc(-c7cnc8c9ccccc9c9ccccc9c8n7)c6)c5ccc43)c2)cc1.c1ccc(-c2cccc3c2oc2c(-n4c5ccccc5c5c6c7ccccc7n(-c7cccc(-c8cnc9c%10ccccc%10c%10ccccc%10c9n8)c7)c6ccc54)cccc23)cc1.c1ccc(-c2cccc3c2sc2c(-n4c5ccccc5c5c6c7ccccc7n(-c7cccc(-c8cnc9c%10ccccc%10c%10ccccc%10c9n8)c7)c6ccc54)cccc23)cc1.c1ccc(-n2c3ccccc3c3c4c5ccccc5n(-c5cccc(-c6cnc7c8ccccc8c8ccccc8c7n6)c5)c4ccc32)cc1
• InChI: InChI=1S/C58H34N4O.C58H34N4S.C58H36N4.C52H30N4O.C52H30N4S.2C52H32N4.C46H28N4/c2*1-2-15-35(16-3-1)38-25-13-26-43-44-27-14-30-52(58(44)63-57(38)43)62-49-29-11-9-24-46(49)54-51(62)32-31-50-53(54)45-23-8-10-28-48(45)61(50)37-18-12-17-36(33-37)47-34-59-55-41-21-6-4-19-39(41)40-20-5-7-22-42(40)56(55)60-47;1-3-16-37(17-4-1)40-32-41(38-18-5-2-6-19-38)35-43(34-40)62-52-29-14-12-27-49(52)56-54(62)31-30-53-55(56)48-26-11-13-28-51(48)61(53)42-21-15-20-39(33-42)50-36-59-57-46-24-9-7-22-44(46)45-23-8-10-25-47(45)58(57)60-50;2*1-3-18-36-33(15-1)34-16-2-4-19-37(34)51-50(36)53-30-41(54-51)31-13-11-14-32(29-31)55-42-23-8-5-20-39(42)48-44(55)27-28-45-49(48)40-21-6-9-24-43(40)56(45)46-25-12-22-38-35-17-7-10-26-47(35)57-52(38)46;1-2-14-33(15-3-1)34-16-12-18-36(30-34)55-45-26-10-8-24-42(45)49-47(55)28-29-48-50(49)43-25-9-11-27-46(43)56(48)37-19-13-17-35(31-37)44-32-53-51-40-22-6-4-20-38(40)39-21-5-7-23-41(39)52(51)54-44;1-2-13-33(14-3-1)34-25-27-36(28-26-34)55-45-23-10-8-21-42(45)49-47(55)29-30-48-50(49)43-22-9-11-24-46(43)56(48)37-16-12-15-35(31-37)44-32-53-51-40-19-6-4-17-38(40)39-18-5-7-20-41(39)52(51)54-44;1-2-14-30(15-3-1)49-39-23-10-8-21-36(39)43-41(49)25-26-42-44(43)37-22-9-11-24-40(37)50(42)31-16-12-13-29(27-31)38-28-47-45-34-19-6-4-17-32(34)33-18-5-7-20-35(33)46(45)48-38/h2*1-34H;1-36H;2*1-30H;2*1-32H;1-28H
• InChIKey: HQIWIYPDNBFLIE-UHFFFAOYSA-N
• XLogP: 112.92
• TPSA: 311.40 Ų
• H-Bond Acceptors: 36
• Rotatable Bonds: 30
• Heavy Atoms: 464
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	5943.11
LogP ≤ 5	112.92
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	36

Frequently Asked Questions

What is the IUPAC name of 9-dibenzofuran-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-dibenzothiophen-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3,5-diphenylphenyl)-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzofuran-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzothiophen-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(3-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(4-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene?

The IUPAC name of 9-dibenzofuran-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-dibenzothiophen-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3,5-diphenylphenyl)-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzofuran-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzothiophen-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(3-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(4-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene (CID 158556429) is 9-dibenzofuran-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-dibenzothiophen-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3,5-diphenylphenyl)-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzofuran-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzothiophen-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(3-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(4-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene.

What is the SMILES notation for 9-dibenzofuran-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-dibenzothiophen-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3,5-diphenylphenyl)-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzofuran-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzothiophen-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(3-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(4-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene?

The canonical SMILES for 9-dibenzofuran-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-dibenzothiophen-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3,5-diphenylphenyl)-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzofuran-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzothiophen-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(3-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(4-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene is c1cc(-c2cnc3c4ccccc4c4ccccc4c3n2)cc(-n2c3ccccc3c3c4c5ccccc5n(-c5cccc6c5oc5ccccc56)c4ccc32)c1.c1cc(-c2cnc3c4ccccc4c4ccccc4c3n2)cc(-n2c3ccccc3c3c4c5ccccc5n(-c5cccc6c5sc5ccccc56)c4ccc32)c1.c1ccc(-c2cc(-c3ccccc3)cc(-n3c4ccccc4c4c5c6ccccc6n(-c6cccc(-c7cnc8c9ccccc9c9ccccc9c8n7)c6)c5ccc43)c2)cc1.c1ccc(-c2ccc(-n3c4ccccc4c4c5c6ccccc6n(-c6cccc(-c7cnc8c9ccccc9c9ccccc9c8n7)c6)c5ccc43)cc2)cc1.c1ccc(-c2cccc(-n3c4ccccc4c4c5c6ccccc6n(-c6cccc(-c7cnc8c9ccccc9c9ccccc9c8n7)c6)c5ccc43)c2)cc1.c1ccc(-c2cccc3c2oc2c(-n4c5ccccc5c5c6c7ccccc7n(-c7cccc(-c8cnc9c%10ccccc%10c%10ccccc%10c9n8)c7)c6ccc54)cccc23)cc1.c1ccc(-c2cccc3c2sc2c(-n4c5ccccc5c5c6c7ccccc7n(-c7cccc(-c8cnc9c%10ccccc%10c%10ccccc%10c9n8)c7)c6ccc54)cccc23)cc1.c1ccc(-n2c3ccccc3c3c4c5ccccc5n(-c5cccc(-c6cnc7c8ccccc8c8ccccc8c7n6)c5)c4ccc32)cc1.

What is the InChIKey of 9-dibenzofuran-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-dibenzothiophen-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3,5-diphenylphenyl)-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzofuran-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzothiophen-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(3-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(4-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene?

The InChIKey is HQIWIYPDNBFLIE-UHFFFAOYSA-N. The full InChI is InChI=1S/C58H34N4O.C58H34N4S.C58H36N4.C52H30N4O.C52H30N4S.2C52H32N4.C46H28N4/c2*1-2-15-35(16-3-1)38-25-13-26-43-44-27-14-30-52(58(44)63-57(38)43)62-49-29-11-9-24-46(49)54-51(62)32-31-50-53(54)45-23-8-10-28-48(45)61(50)37-18-12-17-36(33-37)47-34-59-55-41-21-6-4-19-39(41)40-20-5-7-22-42(40)56(55)60-47;1-3-16-37(17-4-1)40-32-41(38-18-5-2-6-19-38)35-43(34-40)62-52-29-14-12-27-49(52)56-54(62)31-30-53-55(56)48-26-11-13-28-51(48)61(53)42-21-15-20-39(33-42)50-36-59-57-46-24-9-7-22-44(46)45-23-8-10-25-47(45)58(57)60-50;2*1-3-18-36-33(15-1)34-16-2-4-19-37(34)51-50(36)53-30-41(54-51)31-13-11-14-32(29-31)55-42-23-8-5-20-39(42)48-44(55)27-28-45-49(48)40-21-6-9-24-43(40)56(45)46-25-12-22-38-35-17-7-10-26-47(35)57-52(38)46;1-2-14-33(15-3-1)34-16-12-18-36(30-34)55-45-26-10-8-24-42(45)49-47(55)28-29-48-50(49)43-25-9-11-27-46(43)56(48)37-19-13-17-35(31-37)44-32-53-51-40-22-6-4-20-38(40)39-21-5-7-23-41(39)52(51)54-44;1-2-13-33(14-3-1)34-25-27-36(28-26-34)55-45-23-10-8-21-42(45)49-47(55)29-30-48-50(49)43-22-9-11-24-46(43)56(48)37-16-12-15-35(31-37)44-32-53-51-40-19-6-4-17-38(40)39-18-5-7-20-41(39)52(51)54-44;1-2-14-30(15-3-1)49-39-23-10-8-21-36(39)43-41(49)25-26-42-44(43)37-22-9-11-24-40(37)50(42)31-16-12-13-29(27-31)38-28-47-45-34-19-6-4-17-32(34)33-18-5-7-20-35(33)46(45)48-38/h2*1-34H;1-36H;2*1-30H;2*1-32H;1-28H.

What are the key properties of 9-dibenzofuran-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-dibenzothiophen-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3,5-diphenylphenyl)-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzofuran-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzothiophen-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(3-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(4-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene?

9-dibenzofuran-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-dibenzothiophen-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3,5-diphenylphenyl)-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzofuran-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzothiophen-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(3-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(4-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene has a molecular weight of 5943.11 g/mol, XLogP of 112.92, 30 rotatable bonds, 0 hydrogen bond donors, and 36 hydrogen bond acceptors.

Where does this data come from?

All data for 9-dibenzofuran-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-dibenzothiophen-4-yl-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3,5-diphenylphenyl)-14-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-phenyl-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzofuran-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(6-phenyldibenzothiophen-4-yl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(3-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene;9-(3-phenanthro[9,10-b]pyrazin-3-ylphenyl)-14-(4-phenylphenyl)-9,14-diazapentacyclo[11.7.0.02,10.03,8.015,20]icosa-1(13),2(10),3,5,7,11,15,17,19-nonaene is sourced from PubChem (CID 158556429), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).